Literature DB >> 7379306

Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred.

J L Millán, M P Whyte, L V Avioli, W H Fishman.   

Abstract

We used heat inactivation, L-phenylalanine inhibition, and electrophoresis on polyacrylamide gel and cellulose acetate membranes--with and without use of specific antisera against the liver-bone, intestinal, and placental isoenzymes--to distinguish and quantitate the different alkaline phosphatase isoenzymes in sera from 23 adult members of a kindred affected by the adult form of hypophosphatasia. Nine subjects had values for total activity more than two standard deviations below the mean values for age- and sex-matched normal persons. Bone isoenzyme was diminished in all nine, whereas liver isoenzyme was subnormal in only four. Phosphoethanolamine and phosphoserine in the urine of eight hypophosphatasemic individuals correlated inversely with both total and liver alkaline phosphatase activity in their serum, but not with the activity of the bone isoenzyme. Total activity in the serum of adult kindred members correlated best with the circulating liver isoenzyme activity. The findings suggest that altered hepatic metabolism is responsible for the increased urinary excretion of phosphoethanolamine, and perhaps phosphoserine, in hypophosphatasia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379306

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.

Authors:  Cecilia Halling Linder; Sonoko Narisawa; José Luis Millán; Per Magnusson
Journal:  Bone       Date:  2009-07-22       Impact factor: 4.398

2.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

3.  Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia.

Authors:  P M Royce; A Blumberg; R P Zurbrügg; A Zimmermann; J P Colombo; B Steinmann
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

Review 4.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

5.  Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine.

Authors:  C Hummer; J L Millán
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

6.  Infantile hypophosphatasia: enzymatic defect explored with alkaline phosphatase-deficient skin fibroblasts in culture.

Authors:  M P Whyte; S D Rettinger; L A Vrabel
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

7.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

Authors:  M P Whyte; M Landt; L M Ryan; R A Mulivor; P S Henthorn; K N Fedde; J D Mahuren; S P Coburn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Adult hypophosphatasia without apparent skeletal disease: "odontohypophosphatasia" in four heterozygote members of a family.

Authors:  F Eberle; S Hartenfels; H Pralle; A Käbisch
Journal:  Klin Wochenschr       Date:  1984-04-16

9.  The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations.

Authors:  Meik Neufurth; Xiaohong Wang; Emad Tolba; Ingo Lieberwirth; Shunfeng Wang; Heinz C Schröder; Werner E G Müller
Journal:  Biochem Pharmacol       Date:  2020-09-06       Impact factor: 5.858

Review 10.  Alkaline Phosphatase and Hypophosphatasia.

Authors:  José Luis Millán; Michael P Whyte
Journal:  Calcif Tissue Int       Date:  2015-11-21       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.